Table 5.
Role of hypoglycemia fear on health-related quality of life using alternative models (Sulfonylurea Subgroup)
| Variable | EQ-5D (US) | SF-12 MCS | SF-12 PCS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| β | P value | 95% CI for β | β | P value | 95% CI for β | β | P value | 95% CI for β | |
| Model 1 | |||||||||
| Hypo | −0.077 | 0.001 | −0.123 to −0.031 | −6.531 | <0.001 | −9.606 to −3.456 | −1.815 | 0.241 | −4.857 to 1.226 |
| Model 2 | |||||||||
| Hypo | −0.060 | 0.014 | −0.107 to -0.013 | −5.300 | 0.001 | −8.453 to −2.147 | 0.056 | 0.971 | −2.973 to 3.084 |
| HFS | −0.002 | 0.014 | −0.004 to −0.000 | −0.140 | 0.008 | −0.243 to −0.038 | −0.213 | <0.001 | −0.311 to −0.114 |
β = regression coefficient; EQ = EuroQol; Hypo = symptomatic hypoglycemia; HFS = Hypoglycemia Fear Survey; MCS = Mental Component Summary; PCS = Physical Component Summary; SF-12 = 12-item Short Form Health Survey.